10 September 2019

-

Hosted by:
Catalent

Detail

View session Description
NLSDays Pre-Event

Catalent Partnering Day

09:30 - 15:00Malmömässan Conference Center

9:30    Registration and welcome coffee
10:00  Welcome from hosts
10:10  Session 1
11:40  Lunch & Networking
12:10  Session 2
13:40  Pre-arranged meetings (Coffee and Networking for anyone wanting to stay)
15:00  Closing

Free registration opened to all NLSDays participants.

Registration and partnering website opening soon.

Hosted by:
Vinnova

Detail

View session Description
NLSDays Pre-Event

Eurostars Workshop

14:00 - 16:00Malmömässan Conference Center

Welcome and introduction to the workshop and brief intro EUSME

  • Introduction to EUREKA Instruments
  • FR-SE Bilateral Call
  • Eurostars (programme, application & evaluation process). Eurostars in SE. Funding and support to applicants

Eurostars in FR. Funding and support to applicants. FR-SE Bilateral Call

  • Why Eurostars?
  • Consortium building
  • Project results:Continued R&D cooperation? Business cooperation?

Questions from the audience

Hosted by:
Spark Norway
Spark Finland
SciLifeLab
BioInnovation Institute

Detail

View session Description
Get the presentations from the selected finalists and applause the winners

Nordic Life Science Awards

16:30 - 19:00NLSDays Arena

This year we inaugurate the new Nordic Life Science Awards completion, opened to two participants categories, academia and early stage companies.

Part 1 – Academia

“Advancing academic ideas into innovations for patients”

Academia is a key engine for medical innovation and many life science projects becoming commercial successful originate from academic centers. Big ideas very often come from ground-braking academic research. Recognizing that the majority of the global companies made academic-industrial partnerships an integral part of their strategies and opened their R&D organizations to external innovation.

The Nordic Life Science Award for Academia features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivations to advance their ideas into innovations for patients. The session is hosted by SPARK Norway and delivered in collaboration with SPARK Finland, SciLifeLab Sweden and the Danish BioInnovation Institute.

11 September 2019

+

Hosted by:
SwedenBIO

Detail

View session Description

Official Opening Plenary

09:00 - 10:15Plenary Room A

The opening plenary welcomes you all and marks the beginning of the 7thNordic Life Science Days! Get inspired and listen to our highly ambitions Nordic life science agenda.

Moderator(s): Ms. Helena Strigård - Deputy Director General, SwedenBIO

Speaker(s):
Mr. Olivier Duchamp - Managing Director, NLSDays - VP International BD & Promotion, SwedenBIO Ms. Ann Linde - Swedish Minister for Foreign Trade, with responsibility for Nordic affairs Mr. Hans Erik Henriksen - CEO, HealthCare Denmark

Hosted by:
DNB
Nasdaq
Novo Seeds
Sponsored by:
DNB

Detail

View session Description
From seed to market; maintaining a sustainable capital market in the Nordics

Super Session 1 – Financing

10:45 - 12:15Plenary Room A

Measured by the high level of business activities and the impressive number of companies, the Nordic life science sector is strong in an international context and has contributed to many innovations on the global market. Appropriate and timely financing is a must for the Nordic life science companies in order to progress the development of their respective project pipelines. This session highlights specific Nordic features such as the growing number of early to mid-stage companies listed at the stock exchanges and discuss how to maintain a sustainable life science capital market in the Nordics.

Part 1: From seed to IPO “pitch”
Part 2: Stockholm, the capital of IPOs (IPOs as exit possibility for VCs)
Part 3: Maintaining a sustainable life science capital market in the Nordics

Moderator(s): Dr. Sonja Benhamida - Senior Vice President Healthcare, DNB

Speaker(s):
Mr. Stephan Christgau - Senior Partner, Novo Seeds Mr. Andreas Lindblom - CEO, Sciety Mr. Ari-Pekka Laitsaari - Growth Capital and Innovation Finance, European Investment Bank Mr. Shutian Liu - Managing Partner and Founding Partner, Button Capital Mr. Adam Kostyal - Senior Vice President, Nasdaq OMX Mr. Fredrik Konopik - Head of Equity Capital Markets, DNB Markets

10:45 Ferring Pharmaceuticals - Pharmaceutical 11:00 Johnson & Johnson Innovation - Pharmaceutical 11:15 MSD - Pharmaceutical 11:30 Pfizer - Pharmaceutical 11:45 Sanofi - Pharmaceutical 12:00 Amgen - Pharmaceutical

Sponsored by:
MSD

Detail

View session Description
Latest developments in neuroscience R&D

Super Session 2 – Neurosciences

14:00 - 15:30Plenary Room A

Neuroscience has not only proven to be one of the most challenges areas for finding treatments, it is also one of the diseases putting the greatest burden on society. Current treatment will only temporarily improve symptoms but are there new treatments around the corner potentially stopping or significantly delaying the progression of the disease? International experts will share their views on what is possible based on the knowledge currently available.

Moderator(s): Ms. Ingrid Heath - Partner, Adlersson & Heath

Speaker(s):
Dr. Jina Elise Swartz - Global Clinical Development, MSD Dr. Per-Ola Freskgård - CSO, BioArctic Dr. Steffen Thirstrup - Director, NDA Regulatory Advisory Board Dr. Göran Gustafsson - Department Head, Printed Electronics, Biocom Lab/RISE Dr. Patrick Sobocki - Investment Manager, Industrifonden

14:00 Annexin Pharmaceuticals - Biotechnology - Therapeutics & Diagnostics 14:13 Aqilion - Biotechnology - Therapeutics & Diagnostics 14:26 Beactica - Pharmaceutical 14:39 CanImGuide Therapeutics - Biotechnology - Therapeutics & Diagnostics 14:52 Gedea Biotech - Biotechnology - Therapeutics & Diagnostics 15:05 Immunicum - Biotechnology - Therapeutics & Diagnostics 15:18 DelSiTech - Pharmaceutical 15:31 Scandinavian Biopharma - Biotechnology - R&D Services

Hosted by:
SwedenBIO
Sponsored by:
Charles River
IQVIA

Detail

Moderator(s): Mr. Sverre Bengtsson - Co-Founder, Owner and Sr VP Strategic Relations, Pharma Consulting Group

Speaker(s):
Dr. John Montana - Corporate VP, Integrated Drug Discovery & Strategic Projects, Charles River Laboratories Dr. Peter Gaskin - Senior Director, Scientific Advisory Services, Charles River Laboratories Dr. Eric Meldrum - CSO, ENYO Pharma

Hosted by:
SweLife

Detail

View session Description
Accelerating Development of ATMP Technology to Phase 1 Clinical Studies and Beyond

Seminar 2 – Advanced Therapy Medicinal Products

15:45 - 16:45Conference Room C
The session is dedicated to SMEs involved in the development of Advanced Therapy Medicinal Products (ATMPs). The panel will discuss different strategies for SMEs, including going public, pharma collaborations and what big pharma companies are looking for when scouting external innovations.

Moderator(s): Dr. Christina Östberg Lloyd - Clinical Medical Regulatory Director, Novo Nordisk & Chairman, SWELife

Speaker(s):
Prof. Malin Parmar - Associate Professor, Lund University Dr. Mathias Svahn - CEO, NextCell Pharma Dr. Carlos de Sousa - CEO, Immunicum Dr. Christoph Varenhorst - Medical Director, Pfizer Dr. Peter Hovstadius - Chief Scientific Officer Nordics, Novartis

15:45 EY - Professional Services & Consulting 16:01 EIT Health Scandinavia - Public & Non-Profit Organizations 16:14 S-cubed - CRO/CMO/CDMO 16:21 S-cubed - CRO/CMO/CDMO 16:28 Venn Life Sciences - CRO/CMO/CDMO 16:35 GEA - Supplier & Engineering

Hosted by:
Vinnova

Detail

View session Description
Innovative Medicines Initiative (IMI)- What’s in it for me?

Seminar 3 – Funding opportunities for SMEs

17:15 - 18:15Conference Room B

Welcome to an interactive session on Innovative Medicines Initiative (IMI), an EU public-private partnership funding health research and innovation. This is the opportunity for you as an SME, patient organisation, healthcare industry or academia representative or any other key healthcare player, to learn more about how to engage with IMI, upcoming calls, get a SME testimonial and – most of all- a chance to get your questions answered !

Moderator(s): Ms. Caroline Ekstrand - Program Manager, Vinnova

Speaker(s):
Mr. Nicolas Creff - Senior Manager, Research Partnerships and Science Policy and Regulatory Affairs, EFPIA Ms. Magali Poinot - Advisor to Executive Director, IMI Executive Office Dr. Karin von Wachenfeldt - CEO, Truly Labs Dr. Gunnar Sandberg - Chair of IMI State Representative Group and Program Manager, Vinnova Dr. Elisabet Nielsen - Program Manager, Vinnova

Hosted by:
SwedenBIO

Detail

Moderator(s): Ms. Louise Jonshammar - Attorney At Law, AWA

Speaker(s):
Dr. Niclas Nilsson - Head of Open Innovation in Research, Leo Pharma Dr. Magnus Larsson - Vice President, Head of Unit Surface - Process and Formulation, RISE Dr. Michael L. Salgaller - Supervisor, Invention Development and Marketing Unit (IDMU), National Institutes of Health

17:15 Charles River - CRO/CMO/CDMO 17:31 Cobra Biologics - CRO/CMO/CDMO 17:44 Recipharm - CRO/CMO/CDMO 17:57 Coriolis Pharma - CRO/CMO/CDMO 18:10 Mercodia - Supplier & Engineering

Hosted by:
Malmö University
Lund University
Sponsored by:
HealthCap

Detail

View session Description

NLSDays Official Reception

19:00 - 22:30LuftKastellet

An outstanding location overlooking the Øresund bridge combining the raw nature in the best way with a futuristic expression in architecture.

Shuttle busses will depart from MalmöMässan main entrance from 18:30 until 19:30

Shuttle busses will depart from Luftkastellet from 21:30 until 22:30 to Malmömässan and main hotels downtown Malmö.

12 September 2019

+

Hosted by:
Medeon
Lund University
Sponsored by:
MSD

Detail

Moderator(s): Dr. Gaspar Taroncher-Oldenburg - Editor-at-Large, Nature Publishing Group

Speaker(s):
Dr. Michel de Baar - Executive Director, BD&L - Infectious Diseases, Vaccines, Cardiometabolic, Immunology & Inflammation, MSD Mr. Thomas Magnusson - Chairman of the Board, DIOS (Diabetesorganisationen I Sverige) Dr. Damon Tojjar - Managing Director, Easy Diabetes

08:45 Sirion Biotech - Biotechnology - Other 08:52 Vicore Pharma - Biotechnology - R&D Services 09:05 ENYO Pharma - Biotechnology - Therapeutics & Diagnostics 09:18 AstraZeneca - Pharmaceutical 09:34 Bristol-Myers Squibb - Pharmaceutical 09:50 Boehringer Ingelheim - Pharmaceutical

Hosted by:
Oslo Cancer Cluster
Sponsored by:
Ferring Pharmaceuticals
Bristol-Myers Squibb

Detail

Moderator(s): Dr. Gaspar Taroncher-Oldenburg - Editor-at-Large, Nature Publishing Group

Speaker(s):
Dr. Mark Swindells - Chief Operating Officer, Exscientia Ms. Kaisa Helminen - CEO, Aiforia Technologies Dr. Jørn Skibsted Jakobsen - Vice President, Global Clinical Research and Development, Ferring Pharmaceuticals Prof. Carl Borrebaeck - Professor, Lund University Dr. George Coukos - Director Department of Oncology, University of Lausanne

10:45 Cartana - Biotechnology - R&D Services 10:52 Abera Bioscience - Biotechnology - Therapeutics & Diagnostics 10:59 Index Pharmaceuticals - Pharmaceutical 11:06 NextCell Pharma - Biotechnology - Therapeutics & Diagnostics 11:13 Sigrid Therapeutics - Biotechnology - Therapeutics & Diagnostics 11:20 Sinfonia Biotherapeutics - Biotechnology - Therapeutics & Diagnostics 11:27 HepaPredict - CRO/CMO/CDMO 11:34 Ilya Pharma - Pharmaceutical 11:41 Research Institutes of Sweden - Public & Non-Profit Organization 11:48 Research Institutes of Sweden - Public & Non-Profit Organization 11:55 S-cubed - CRO/CMO/CDMO 12:02 Immuneed - CRO/CMO/CDMO 12:09 LGC Group - CRO/CMO/CDMO 12:16 Particle Analytical - CRO/CMO/CDMO

Hosted by:
SwedenBIO
Sponsored by:
Astrazeneca

Detail

Moderator(s): Dr. Ulrica Sehlstedt - Management Consultant, Arthur D. Little

Speaker(s):
Dr. Magnus R. Björsne - CEO, AZ BioVentureHub Dr. Anders Holmén - VP and Head of Pharmaceutical Sciences, BioPharmceuticals R&D, AstraZeneca

Hosted by:
Lund University
Malmö University

Detail

View session Description
Now is the time! Learn why and how to take advantage of unique large scale facilities for innovation and growth

Seminar 6 MAX IV – ESS – HALOS

14:00 - 15:30Main Hall

MAX IV and ESS, DESY and European XFEL position Northern Europe as a globally unique region for Life Science Innovation and Research. Get inspiration on how to develop your products and stay competitive within your area. The session will include an interactive panel discussion and take off from the newly started EU project ‘Hanseatic League of Science (HALOS)’, www.halos.lu.se

Speaker(s):
Prof. Erik Renström - Professor, Lund University Assoc. Prof. Kajsa Paulsson - Associate Professor, Lund University Dr. Selma Maric - Coordinator Industrial Relation, Life Sciences, MAX IV Assoc. Prof. Tomas Lundqvist - Coordinator for Large Scale Research Infrastructures, RISE Dr. Anna Sandström - Science Policy and Relations Director Europe, AstraZeneca Dr. Anna Stenstam - CEO, CR Competence